Coronavirus vaccine news: Serum Institute of India CEO Adar Poonawalla had earlier stated that the company would reserve 50 per cent of the vaccine doses for use in India

Serum Institute had earlier sought permission from DCGI for conducting \"phase 2/3 human clinical trials\" of potential vaccine; Pune-based drug firm says vaccine will be called 'Covidshield' in India

Of the total vaccine candidates, 140 are at the pre-clinical stage, while 19 have entered phase 1. A total of 13 vaccines have entered in expanded safety trials of Phase 2, while four vaccine candidates are undergoing large-scale efficacy trials in Phase 3

Adar Poonawalla's father Cyrus has reportedly agreed to set aside 60,000 vials of COVID-19 vaccine exclusively for the Parsi community to which he belongs

Coronavirus vaccine news: Serum Institute of India will start trials of the Oxford University-AstraZeneca COVID-19 vaccine by the end of August. Up to 5,000 Indian volunteers would be included in the tests

Coronavirus (Covid-19) Vaccine News Latest Updates:  The study showed that curcumin can prevent Transmissible gastroenteritis virus (TGEV)- an alpha-group coronavirus that infects pigs, from infecting cells. The higher doses of curcumin were also found to kill virus particles

Coronavirus (Covid-19) Vaccine News Latest Updates: Head of WHO's emergencies programme Mike Ryan has said that while there are multiple contenders and many companies have made significant progress, the likely time for a coronavirus vaccine in the market is not before 2021

Pfizer will deliver the doses if the product receives Emergency Use Authorization or licensure from the U.S. Food and Drug Administration, after completing demonstration of safety and efficacy in a large Phase 3 clinical trial

The Serum Institute of India will begin phase-III human clinical trials of the COVID-19 vaccine in the country in August with 4,000-5,000 volunteers, said its CEO Adar Poonawalla

This is Netflix's second mobile plan in India. Last year, the OTT giant launched Rs 199 mobile plan with support for SD streaming (Support Definition)

Maharashtra's COVID-19 tally has increased to 3,27,031 with 8,369 fresh cases. With 246 new deaths, the state's toll has climbed to 12,276

Serum Institute of India CEO Adar Poonawalla expressed certitude that the governments across low-and-middle-income nations will procure and distribute the COVID-19 vaccine without charge

Coronavirus (COVID-19) Vaccine News Latest Updates: Dr Cyrus Poonawalla, Chairman of the Poonawalla Group, says a just a few million doses of the potential COVID-19 vaccine will not be enough and the company intends to manufacture around 1 billion doses after getting all the necessary approvals

Vaccine major Serum Institute of India's CEO Adar Poonawalla said on Monday the company will apply for COVID-19 vaccine trials within a week and will soon begin manufacturing the vaccine, developed by Oxford University, in large volumes

Coronavirus vaccine news update: Goldman Sachs believes that a coronavirus vaccine could be approved by the end of the year. It predicts Moderna and Pfizer's candidates to be the first ones to pass regulatory hurdles

Poonawalla's remark came after the rapper West, who in his serious bid for the United States presidential election said, \"they want to put chips inside us. They want to do all kinds of things with us\"

Coronavirus vaccine news update: Serum Institute of India that is producing around four vaccine candidates including the Oxford University-AstraZeneca coronavirus candidate has said that it is expected to launch a candidate by the end of six months

Coronavirus vaccine update: Twelve hospitals have been chosen for COVAXIN trials in the country. Bharat Biotech's COVAXIN is undergoing quality and safety tests before the doses are administered to volunteers

Poonawalla also said that SII will talk about it only when the vaccine is in Phase 3 trials

In China, an activated experimental corona vaccine developed by scientists  has shown effective protection against COVD-19 infection in animal trials